p re ss cas9 expression cassette in lenticrisprv2 Search Results


90
GenScript corporation cas9 third generation lentivirus construct (lenticrisprv2
Cas9 Third Generation Lentivirus Construct (Lenticrisprv2, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/p+re+ss+cas9+expression+cassette+in+lenticrisprv2/cas9+protein/us10899831-1550-6-17
Average 90 stars, based on 1 article reviews
cas9 third generation lentivirus construct (lenticrisprv2 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

96
Addgene inc nuclease deficient cas9
( A ) Schematic summary of the enChIP procedure. A 3xFLAG-dCas9-HA-2xNLS fusion protein (FLAG-dCas9) consisting of an N-terminal triple FLAG (3xFLAG) epitope tag, catalytically inactive <t>Cas9</t> endonuclease (dCas9), C-terminal human influenza hemagglutinin (HA) epitope tag and tandem nuclear localization signal (2xNLS) is expressed with one or more guide RNA (gRNA) in an appropriate cell context. Cells are crosslinked, chromatin is fragmented and complexes containing FLAG-dCas9 are immunoprecipitated with an anti-FLAG antibody. After reversing the crosslinks, molecules associated with the targeted genomic region are purified and identified by downstream analyses including mass spectrometry and next-generation sequencing. Adapted from ). ( B–E ) ChIP-qPCR enrichment of NuRD complex components CHD4 ( B ), HDAC2 ( C ), MTA2 ( D ) and MBD2 ( E ) along the D4Z4 repeat in MB2401 control myoblasts. The Chr18q12 amplicon contains no CpG dinucleotides and serves as a negative control site, while the TMEM130 promoter is occupied by NuRD complex components in published ENCODE datasets and functions as a positive control locus. Error bars denote the standard deviation from the mean of three biological replicates. Statistical significance was calculated by comparing the specific pulldown to the IgG control at each site using a two-tailed, two-sample Mann-Whitney U test. *, p≤0.05; ns, not significant, p>0.05. See also . 10.7554/eLife.31023.005 Figure 1—source data 1. Source data for . This file contains the source data used to make the graphs presented in and . GraphPad Prism was utilized to visually represent the quantitative data.
Nuclease Deficient Cas9, supplied by Addgene inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/p+re+ss+cas9+expression+cassette+in+lenticrisprv2/lentiCRISPR+v2+(Plasmid+%2352961)/pmc05849414-38-17-22
Average 96 stars, based on 1 article reviews
nuclease deficient cas9 - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

94
Addgene inc crispr cas9 plasmids
( A ) Schematic summary of the enChIP procedure. A 3xFLAG-dCas9-HA-2xNLS fusion protein (FLAG-dCas9) consisting of an N-terminal triple FLAG (3xFLAG) epitope tag, catalytically inactive <t>Cas9</t> endonuclease (dCas9), C-terminal human influenza hemagglutinin (HA) epitope tag and tandem nuclear localization signal (2xNLS) is expressed with one or more guide RNA (gRNA) in an appropriate cell context. Cells are crosslinked, chromatin is fragmented and complexes containing FLAG-dCas9 are immunoprecipitated with an anti-FLAG antibody. After reversing the crosslinks, molecules associated with the targeted genomic region are purified and identified by downstream analyses including mass spectrometry and next-generation sequencing. Adapted from ). ( B–E ) ChIP-qPCR enrichment of NuRD complex components CHD4 ( B ), HDAC2 ( C ), MTA2 ( D ) and MBD2 ( E ) along the D4Z4 repeat in MB2401 control myoblasts. The Chr18q12 amplicon contains no CpG dinucleotides and serves as a negative control site, while the TMEM130 promoter is occupied by NuRD complex components in published ENCODE datasets and functions as a positive control locus. Error bars denote the standard deviation from the mean of three biological replicates. Statistical significance was calculated by comparing the specific pulldown to the IgG control at each site using a two-tailed, two-sample Mann-Whitney U test. *, p≤0.05; ns, not significant, p>0.05. See also . 10.7554/eLife.31023.005 Figure 1—source data 1. Source data for . This file contains the source data used to make the graphs presented in and . GraphPad Prism was utilized to visually represent the quantitative data.
Crispr Cas9 Plasmids, supplied by Addgene inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/p+re+ss+cas9+expression+cassette+in+lenticrisprv2/lentiCRISPRv2+hygro+(Plasmid+%2398291)/pmc06427001-205-0-11
Average 94 stars, based on 1 article reviews
crispr cas9 plasmids - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

97
Addgene inc vector lenticrisprv2 expressing cas9 protein
( A ) Schematic summary of the enChIP procedure. A 3xFLAG-dCas9-HA-2xNLS fusion protein (FLAG-dCas9) consisting of an N-terminal triple FLAG (3xFLAG) epitope tag, catalytically inactive <t>Cas9</t> endonuclease (dCas9), C-terminal human influenza hemagglutinin (HA) epitope tag and tandem nuclear localization signal (2xNLS) is expressed with one or more guide RNA (gRNA) in an appropriate cell context. Cells are crosslinked, chromatin is fragmented and complexes containing FLAG-dCas9 are immunoprecipitated with an anti-FLAG antibody. After reversing the crosslinks, molecules associated with the targeted genomic region are purified and identified by downstream analyses including mass spectrometry and next-generation sequencing. Adapted from ). ( B–E ) ChIP-qPCR enrichment of NuRD complex components CHD4 ( B ), HDAC2 ( C ), MTA2 ( D ) and MBD2 ( E ) along the D4Z4 repeat in MB2401 control myoblasts. The Chr18q12 amplicon contains no CpG dinucleotides and serves as a negative control site, while the TMEM130 promoter is occupied by NuRD complex components in published ENCODE datasets and functions as a positive control locus. Error bars denote the standard deviation from the mean of three biological replicates. Statistical significance was calculated by comparing the specific pulldown to the IgG control at each site using a two-tailed, two-sample Mann-Whitney U test. *, p≤0.05; ns, not significant, p>0.05. See also . 10.7554/eLife.31023.005 Figure 1—source data 1. Source data for . This file contains the source data used to make the graphs presented in and . GraphPad Prism was utilized to visually represent the quantitative data.
Vector Lenticrisprv2 Expressing Cas9 Protein, supplied by Addgene inc, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/p+re+ss+cas9+expression+cassette+in+lenticrisprv2/Cas9+sgRNA+vector+(Plasmid+%2368463)/pm39021420-61-13-20
Average 97 stars, based on 1 article reviews
vector lenticrisprv2 expressing cas9 protein - by Bioz Stars, 2026-11
97/100 stars
  Buy from Supplier

98
Addgene inc immunity lenticrisprv2 puro addgene rrid addgene 98290 nlrc3 crispr cas9
( A ) Schematic summary of the enChIP procedure. A 3xFLAG-dCas9-HA-2xNLS fusion protein (FLAG-dCas9) consisting of an N-terminal triple FLAG (3xFLAG) epitope tag, catalytically inactive <t>Cas9</t> endonuclease (dCas9), C-terminal human influenza hemagglutinin (HA) epitope tag and tandem nuclear localization signal (2xNLS) is expressed with one or more guide RNA (gRNA) in an appropriate cell context. Cells are crosslinked, chromatin is fragmented and complexes containing FLAG-dCas9 are immunoprecipitated with an anti-FLAG antibody. After reversing the crosslinks, molecules associated with the targeted genomic region are purified and identified by downstream analyses including mass spectrometry and next-generation sequencing. Adapted from ). ( B–E ) ChIP-qPCR enrichment of NuRD complex components CHD4 ( B ), HDAC2 ( C ), MTA2 ( D ) and MBD2 ( E ) along the D4Z4 repeat in MB2401 control myoblasts. The Chr18q12 amplicon contains no CpG dinucleotides and serves as a negative control site, while the TMEM130 promoter is occupied by NuRD complex components in published ENCODE datasets and functions as a positive control locus. Error bars denote the standard deviation from the mean of three biological replicates. Statistical significance was calculated by comparing the specific pulldown to the IgG control at each site using a two-tailed, two-sample Mann-Whitney U test. *, p≤0.05; ns, not significant, p>0.05. See also . 10.7554/eLife.31023.005 Figure 1—source data 1. Source data for . This file contains the source data used to make the graphs presented in and . GraphPad Prism was utilized to visually represent the quantitative data.
Immunity Lenticrisprv2 Puro Addgene Rrid Addgene 98290 Nlrc3 Crispr Cas9, supplied by Addgene inc, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/p+re+ss+cas9+expression+cassette+in+lenticrisprv2/lentiCRISPRv2+puro+(Plasmid+%2398290)/pm36952341-330-30-33
Average 98 stars, based on 1 article reviews
immunity lenticrisprv2 puro addgene rrid addgene 98290 nlrc3 crispr cas9 - by Bioz Stars, 2026-11
98/100 stars
  Buy from Supplier

95
Addgene inc crispr cas9 plasmid
( A ) Schematic summary of the enChIP procedure. A 3xFLAG-dCas9-HA-2xNLS fusion protein (FLAG-dCas9) consisting of an N-terminal triple FLAG (3xFLAG) epitope tag, catalytically inactive <t>Cas9</t> endonuclease (dCas9), C-terminal human influenza hemagglutinin (HA) epitope tag and tandem nuclear localization signal (2xNLS) is expressed with one or more guide RNA (gRNA) in an appropriate cell context. Cells are crosslinked, chromatin is fragmented and complexes containing FLAG-dCas9 are immunoprecipitated with an anti-FLAG antibody. After reversing the crosslinks, molecules associated with the targeted genomic region are purified and identified by downstream analyses including mass spectrometry and next-generation sequencing. Adapted from ). ( B–E ) ChIP-qPCR enrichment of NuRD complex components CHD4 ( B ), HDAC2 ( C ), MTA2 ( D ) and MBD2 ( E ) along the D4Z4 repeat in MB2401 control myoblasts. The Chr18q12 amplicon contains no CpG dinucleotides and serves as a negative control site, while the TMEM130 promoter is occupied by NuRD complex components in published ENCODE datasets and functions as a positive control locus. Error bars denote the standard deviation from the mean of three biological replicates. Statistical significance was calculated by comparing the specific pulldown to the IgG control at each site using a two-tailed, two-sample Mann-Whitney U test. *, p≤0.05; ns, not significant, p>0.05. See also . 10.7554/eLife.31023.005 Figure 1—source data 1. Source data for . This file contains the source data used to make the graphs presented in and . GraphPad Prism was utilized to visually represent the quantitative data.
Crispr Cas9 Plasmid, supplied by Addgene inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/p+re+ss+cas9+expression+cassette+in+lenticrisprv2/LentiCRISPRv2-mCherry+(Plasmid+%2399154)/pmc11476720-167-12-15
Average 95 stars, based on 1 article reviews
crispr cas9 plasmid - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

90
Promega lenticrisprv2-gzap-cas9-p2a-gfp plasmid
( A ) Schematic summary of the enChIP procedure. A 3xFLAG-dCas9-HA-2xNLS fusion protein (FLAG-dCas9) consisting of an N-terminal triple FLAG (3xFLAG) epitope tag, catalytically inactive <t>Cas9</t> endonuclease (dCas9), C-terminal human influenza hemagglutinin (HA) epitope tag and tandem nuclear localization signal (2xNLS) is expressed with one or more guide RNA (gRNA) in an appropriate cell context. Cells are crosslinked, chromatin is fragmented and complexes containing FLAG-dCas9 are immunoprecipitated with an anti-FLAG antibody. After reversing the crosslinks, molecules associated with the targeted genomic region are purified and identified by downstream analyses including mass spectrometry and next-generation sequencing. Adapted from ). ( B–E ) ChIP-qPCR enrichment of NuRD complex components CHD4 ( B ), HDAC2 ( C ), MTA2 ( D ) and MBD2 ( E ) along the D4Z4 repeat in MB2401 control myoblasts. The Chr18q12 amplicon contains no CpG dinucleotides and serves as a negative control site, while the TMEM130 promoter is occupied by NuRD complex components in published ENCODE datasets and functions as a positive control locus. Error bars denote the standard deviation from the mean of three biological replicates. Statistical significance was calculated by comparing the specific pulldown to the IgG control at each site using a two-tailed, two-sample Mann-Whitney U test. *, p≤0.05; ns, not significant, p>0.05. See also . 10.7554/eLife.31023.005 Figure 1—source data 1. Source data for . This file contains the source data used to make the graphs presented in and . GraphPad Prism was utilized to visually represent the quantitative data.
Lenticrisprv2 Gzap Cas9 P2a Gfp Plasmid, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/p+re+ss+cas9+expression+cassette+in+lenticrisprv2/crispr+cas9+plasmid+targeting+first+methionine+site+polr2+gene++cct+ccg%E2%80%8Bcca%E2%80%8Btgc%E2%80%8Bacg%E2%80%8Bggg%E2%80%8Bgtg%E2%80%8Bgc/pmc09493364-47-7-12
Average 90 stars, based on 1 article reviews
lenticrisprv2-gzap-cas9-p2a-gfp plasmid - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

96
Addgene inc lentiviral dual grna cas9 expression vector lenticrisprv2 blast
A : Representative immunoblots of n = 3 experiments done using total lysates from BLM wild-type (Wt), BLM empty vector (EV)-infected, or two different CRISPR/ <t>Cas9</t> -mediated MEK5 k.o. single cell clones (SCC) of BLM treated with diluent (ctrl) or 25 nM Tram for 14 days, showing expression of selected cell cycle proteins. ERK5 phosphorylation and DUSP4 suppression confirm Tram functionality. Successful MEK5 gene disruption was analysed by MEK5 immunoblot and functionally evaluated by immunoblotting for ERK5, which confirmed absent ERK5 autophosphorylation. Tubulin served as loading control. B : Representative cell cycle profiles of n = 2 experiments, as determined by flow cytometric analysis of the indicated PI-stained conditions with percentages of S-phase cells indicated. C : Cell doubling time analysis representative of n = 2 experiments with running times of 2–5 weeks performed with Wt BLM or the indicated MEK5 k.o. BLM SCCs cultured in absence or presence of Tram. The shown experiment run over a period of five weeks.
Lentiviral Dual Grna Cas9 Expression Vector Lenticrisprv2 Blast, supplied by Addgene inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/p+re+ss+cas9+expression+cassette+in+lenticrisprv2/lentiCRISPR+v2-Blast+(Plasmid+%2383480)/pmc12501213-192-6-13
Average 96 stars, based on 1 article reviews
lentiviral dual grna cas9 expression vector lenticrisprv2 blast - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

96
Addgene inc crispr cas9 vector
A : Representative immunoblots of n = 3 experiments done using total lysates from BLM wild-type (Wt), BLM empty vector (EV)-infected, or two different CRISPR/ <t>Cas9</t> -mediated MEK5 k.o. single cell clones (SCC) of BLM treated with diluent (ctrl) or 25 nM Tram for 14 days, showing expression of selected cell cycle proteins. ERK5 phosphorylation and DUSP4 suppression confirm Tram functionality. Successful MEK5 gene disruption was analysed by MEK5 immunoblot and functionally evaluated by immunoblotting for ERK5, which confirmed absent ERK5 autophosphorylation. Tubulin served as loading control. B : Representative cell cycle profiles of n = 2 experiments, as determined by flow cytometric analysis of the indicated PI-stained conditions with percentages of S-phase cells indicated. C : Cell doubling time analysis representative of n = 2 experiments with running times of 2–5 weeks performed with Wt BLM or the indicated MEK5 k.o. BLM SCCs cultured in absence or presence of Tram. The shown experiment run over a period of five weeks.
Crispr Cas9 Vector, supplied by Addgene inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/p+re+ss+cas9+expression+cassette+in+lenticrisprv2/CRISPR-SP-Cas9+reporter+(Plasmid+%2362733)/pmc06675906-238-15-18
Average 96 stars, based on 1 article reviews
crispr cas9 vector - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

96
Addgene inc spcas9
A : Representative immunoblots of n = 3 experiments done using total lysates from BLM wild-type (Wt), BLM empty vector (EV)-infected, or two different CRISPR/ <t>Cas9</t> -mediated MEK5 k.o. single cell clones (SCC) of BLM treated with diluent (ctrl) or 25 nM Tram for 14 days, showing expression of selected cell cycle proteins. ERK5 phosphorylation and DUSP4 suppression confirm Tram functionality. Successful MEK5 gene disruption was analysed by MEK5 immunoblot and functionally evaluated by immunoblotting for ERK5, which confirmed absent ERK5 autophosphorylation. Tubulin served as loading control. B : Representative cell cycle profiles of n = 2 experiments, as determined by flow cytometric analysis of the indicated PI-stained conditions with percentages of S-phase cells indicated. C : Cell doubling time analysis representative of n = 2 experiments with running times of 2–5 weeks performed with Wt BLM or the indicated MEK5 k.o. BLM SCCs cultured in absence or presence of Tram. The shown experiment run over a period of five weeks.
Spcas9, supplied by Addgene inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/p+re+ss+cas9+expression+cassette+in+lenticrisprv2/SP-Cas9+(Plasmid+%2362731)/pm33087932-228-3-13
Average 96 stars, based on 1 article reviews
spcas9 - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

95
Addgene inc sgatg5 cas9
A : Representative immunoblots of n = 3 experiments done using total lysates from BLM wild-type (Wt), BLM empty vector (EV)-infected, or two different CRISPR/ <t>Cas9</t> -mediated MEK5 k.o. single cell clones (SCC) of BLM treated with diluent (ctrl) or 25 nM Tram for 14 days, showing expression of selected cell cycle proteins. ERK5 phosphorylation and DUSP4 suppression confirm Tram functionality. Successful MEK5 gene disruption was analysed by MEK5 immunoblot and functionally evaluated by immunoblotting for ERK5, which confirmed absent ERK5 autophosphorylation. Tubulin served as loading control. B : Representative cell cycle profiles of n = 2 experiments, as determined by flow cytometric analysis of the indicated PI-stained conditions with percentages of S-phase cells indicated. C : Cell doubling time analysis representative of n = 2 experiments with running times of 2–5 weeks performed with Wt BLM or the indicated MEK5 k.o. BLM SCCs cultured in absence or presence of Tram. The shown experiment run over a period of five weeks.
Sgatg5 Cas9, supplied by Addgene inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/p+re+ss+cas9+expression+cassette+in+lenticrisprv2/LentiCRISPRv2-ATG5+(Plasmid+%2399573)/pm33164641-342-13-15
Average 95 stars, based on 1 article reviews
sgatg5 cas9 - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

90
Ribobio co sirnas of igf2bp3, mettl3, mcm5, notch1, sirt1, and hur
A : Representative immunoblots of n = 3 experiments done using total lysates from BLM wild-type (Wt), BLM empty vector (EV)-infected, or two different CRISPR/ <t>Cas9</t> -mediated MEK5 k.o. single cell clones (SCC) of BLM treated with diluent (ctrl) or 25 nM Tram for 14 days, showing expression of selected cell cycle proteins. ERK5 phosphorylation and DUSP4 suppression confirm Tram functionality. Successful MEK5 gene disruption was analysed by MEK5 immunoblot and functionally evaluated by immunoblotting for ERK5, which confirmed absent ERK5 autophosphorylation. Tubulin served as loading control. B : Representative cell cycle profiles of n = 2 experiments, as determined by flow cytometric analysis of the indicated PI-stained conditions with percentages of S-phase cells indicated. C : Cell doubling time analysis representative of n = 2 experiments with running times of 2–5 weeks performed with Wt BLM or the indicated MEK5 k.o. BLM SCCs cultured in absence or presence of Tram. The shown experiment run over a period of five weeks.
Sirnas Of Igf2bp3, Mettl3, Mcm5, Notch1, Sirt1, And Hur, supplied by Ribobio co, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/p+re+ss+cas9+expression+cassette+in+lenticrisprv2/igf2bp3+sirna/pmc10369244-156-25-38
Average 90 stars, based on 1 article reviews
sirnas of igf2bp3, mettl3, mcm5, notch1, sirt1, and hur - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

Image Search Results


( A ) Schematic summary of the enChIP procedure. A 3xFLAG-dCas9-HA-2xNLS fusion protein (FLAG-dCas9) consisting of an N-terminal triple FLAG (3xFLAG) epitope tag, catalytically inactive Cas9 endonuclease (dCas9), C-terminal human influenza hemagglutinin (HA) epitope tag and tandem nuclear localization signal (2xNLS) is expressed with one or more guide RNA (gRNA) in an appropriate cell context. Cells are crosslinked, chromatin is fragmented and complexes containing FLAG-dCas9 are immunoprecipitated with an anti-FLAG antibody. After reversing the crosslinks, molecules associated with the targeted genomic region are purified and identified by downstream analyses including mass spectrometry and next-generation sequencing. Adapted from ). ( B–E ) ChIP-qPCR enrichment of NuRD complex components CHD4 ( B ), HDAC2 ( C ), MTA2 ( D ) and MBD2 ( E ) along the D4Z4 repeat in MB2401 control myoblasts. The Chr18q12 amplicon contains no CpG dinucleotides and serves as a negative control site, while the TMEM130 promoter is occupied by NuRD complex components in published ENCODE datasets and functions as a positive control locus. Error bars denote the standard deviation from the mean of three biological replicates. Statistical significance was calculated by comparing the specific pulldown to the IgG control at each site using a two-tailed, two-sample Mann-Whitney U test. *, p≤0.05; ns, not significant, p>0.05. See also . 10.7554/eLife.31023.005 Figure 1—source data 1. Source data for . This file contains the source data used to make the graphs presented in and . GraphPad Prism was utilized to visually represent the quantitative data.

Journal: eLife

Article Title: NuRD and CAF-1-mediated silencing of the D4Z4 array is modulated by DUX4-induced MBD3L proteins

doi: 10.7554/eLife.31023

Figure Lengend Snippet: ( A ) Schematic summary of the enChIP procedure. A 3xFLAG-dCas9-HA-2xNLS fusion protein (FLAG-dCas9) consisting of an N-terminal triple FLAG (3xFLAG) epitope tag, catalytically inactive Cas9 endonuclease (dCas9), C-terminal human influenza hemagglutinin (HA) epitope tag and tandem nuclear localization signal (2xNLS) is expressed with one or more guide RNA (gRNA) in an appropriate cell context. Cells are crosslinked, chromatin is fragmented and complexes containing FLAG-dCas9 are immunoprecipitated with an anti-FLAG antibody. After reversing the crosslinks, molecules associated with the targeted genomic region are purified and identified by downstream analyses including mass spectrometry and next-generation sequencing. Adapted from ). ( B–E ) ChIP-qPCR enrichment of NuRD complex components CHD4 ( B ), HDAC2 ( C ), MTA2 ( D ) and MBD2 ( E ) along the D4Z4 repeat in MB2401 control myoblasts. The Chr18q12 amplicon contains no CpG dinucleotides and serves as a negative control site, while the TMEM130 promoter is occupied by NuRD complex components in published ENCODE datasets and functions as a positive control locus. Error bars denote the standard deviation from the mean of three biological replicates. Statistical significance was calculated by comparing the specific pulldown to the IgG control at each site using a two-tailed, two-sample Mann-Whitney U test. *, p≤0.05; ns, not significant, p>0.05. See also . 10.7554/eLife.31023.005 Figure 1—source data 1. Source data for . This file contains the source data used to make the graphs presented in and . GraphPad Prism was utilized to visually represent the quantitative data.

Article Snippet: Recombinant DNA reagent , pZLCv2-3xFLAG-dCas9-HA-2xNLS , This paper , Addgene plasmid #106357 , Lentiviral vector expressing FLAG-tagged, nuclease-deficient Cas9 (generated using lentiCRISPRv2 [Addgene plasmid #52961] and pHR-SFFV-KRAB-dCas9-P2A-mCherry [Addgene plasmid #60954]).

Techniques: Immunoprecipitation, Purification, Mass Spectrometry, Next-Generation Sequencing, ChIP-qPCR, Control, Amplification, Negative Control, Positive Control, Standard Deviation, Two Tailed Test, MANN-WHITNEY

Journal: eLife

Article Title: NuRD and CAF-1-mediated silencing of the D4Z4 array is modulated by DUX4-induced MBD3L proteins

doi: 10.7554/eLife.31023

Figure Lengend Snippet:

Article Snippet: Recombinant DNA reagent , pZLCv2-3xFLAG-dCas9-HA-2xNLS , This paper , Addgene plasmid #106357 , Lentiviral vector expressing FLAG-tagged, nuclease-deficient Cas9 (generated using lentiCRISPRv2 [Addgene plasmid #52961] and pHR-SFFV-KRAB-dCas9-P2A-mCherry [Addgene plasmid #60954]).

Techniques: Recombinant, Plasmid Preparation, Expressing, Generated, Modification, Knock-Out, Software

A : Representative immunoblots of n = 3 experiments done using total lysates from BLM wild-type (Wt), BLM empty vector (EV)-infected, or two different CRISPR/ Cas9 -mediated MEK5 k.o. single cell clones (SCC) of BLM treated with diluent (ctrl) or 25 nM Tram for 14 days, showing expression of selected cell cycle proteins. ERK5 phosphorylation and DUSP4 suppression confirm Tram functionality. Successful MEK5 gene disruption was analysed by MEK5 immunoblot and functionally evaluated by immunoblotting for ERK5, which confirmed absent ERK5 autophosphorylation. Tubulin served as loading control. B : Representative cell cycle profiles of n = 2 experiments, as determined by flow cytometric analysis of the indicated PI-stained conditions with percentages of S-phase cells indicated. C : Cell doubling time analysis representative of n = 2 experiments with running times of 2–5 weeks performed with Wt BLM or the indicated MEK5 k.o. BLM SCCs cultured in absence or presence of Tram. The shown experiment run over a period of five weeks.

Journal: Cell Death & Disease

Article Title: MEK5/ERK5 inhibition sensitizes NRAS -mutant melanoma to MAPK-targeted therapy by preventing Cyclin D/CDK4-mediated G1/S progression

doi: 10.1038/s41419-025-08036-7

Figure Lengend Snippet: A : Representative immunoblots of n = 3 experiments done using total lysates from BLM wild-type (Wt), BLM empty vector (EV)-infected, or two different CRISPR/ Cas9 -mediated MEK5 k.o. single cell clones (SCC) of BLM treated with diluent (ctrl) or 25 nM Tram for 14 days, showing expression of selected cell cycle proteins. ERK5 phosphorylation and DUSP4 suppression confirm Tram functionality. Successful MEK5 gene disruption was analysed by MEK5 immunoblot and functionally evaluated by immunoblotting for ERK5, which confirmed absent ERK5 autophosphorylation. Tubulin served as loading control. B : Representative cell cycle profiles of n = 2 experiments, as determined by flow cytometric analysis of the indicated PI-stained conditions with percentages of S-phase cells indicated. C : Cell doubling time analysis representative of n = 2 experiments with running times of 2–5 weeks performed with Wt BLM or the indicated MEK5 k.o. BLM SCCs cultured in absence or presence of Tram. The shown experiment run over a period of five weeks.

Article Snippet: BLM, lentiCRISPR_zeo, a derivative of the lentiviral dual gRNA/ Cas9 expression vector lentiCRISPRv2-Blast (Addgene_83480) replacing the blasticidin R gene by a zeocin R gene was used.

Techniques: Western Blot, Plasmid Preparation, Infection, CRISPR, Clone Assay, Expressing, Phospho-proteomics, Disruption, Control, Staining, Cell Culture